» Articles » PMID: 33219313

MDMA-induced Changes in Within-network Connectivity Contradict the Specificity of These Alterations for the Effects of Serotonergic Hallucinogens

Overview
Date 2020 Nov 21
PMID 33219313
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

It has been reported that serotonergic hallucinogens like lysergic acid diethylamide (LSD) induce decreases in functional connectivity within various resting-state networks. These alterations were seen as reflecting specific neuronal effects of hallucinogens and it was speculated that these shifts in connectivity underlie the characteristic subjective drug effects. In this study, we test the hypothesis that these alterations are not specific for hallucinogens but that they can be induced by monoaminergic stimulation using the non-hallucinogenic serotonin-norepinephrine-dopamine releasing agent 3,4-methylenedioxymethamphetamine (MDMA). In a randomized, placebo-controlled, double-blind, crossover design, 45 healthy participants underwent functional magnetic resonance imaging (fMRI) following oral administration of 125 mg MDMA. The networks under question were identified using independent component analysis (ICA) and were tested with regard to within-network connectivity. Results revealed decreased connectivity within two visual networks, the default mode network (DMN), and the sensorimotor network. These findings were almost identical to the results previously reported for hallucinogenic drugs. Therefore, our results suggest that monoaminergic substances can induce widespread changes in within-network connectivity in the absence of marked subjective drug effects. This contradicts the notion that these alterations can be regarded as specific for serotonergic hallucinogens. However, changes within the DMN might explain antidepressants effects of some of these substances.

Citing Articles

Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine.

Avram M, Fortea L, Wollner L, Coenen R, Korda A, Rogg H Mol Psychiatry. 2024; .

PMID: 39261671 DOI: 10.1038/s41380-024-02734-y.


Direct serotonin release in humans shapes aversive learning and inhibition.

Colwell M, Tagomori H, Shang F, Cheng H, Wigg C, Browning M Nat Commun. 2024; 15(1):6617.

PMID: 39122687 PMC: 11315928. DOI: 10.1038/s41467-024-50394-x.


Psilocybin desynchronizes the human brain.

Siegel J, Subramanian S, Perry D, Kay B, Gordon E, Laumann T Nature. 2024; 632(8023):131-138.

PMID: 39020167 PMC: 11291293. DOI: 10.1038/s41586-024-07624-5.


Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review.

Yu Z, Burback L, Winkler O, Xu L, Dennett L, Vermetten E Front Psychiatry. 2024; 15:1386321.

PMID: 38807690 PMC: 11131165. DOI: 10.3389/fpsyt.2024.1386321.


Exploring psychedelic-assisted therapy in the treatment of functional seizures: A review of underlying mechanisms and associated brain networks.

Lewis E, Jaeger A, Girn M, Omene E, Brendle M, Argento E J Psychopharmacol. 2024; 38(5):407-416.

PMID: 38654554 PMC: 11102649. DOI: 10.1177/02698811241248395.


References
1.
Yan C, Wang X, Zuo X, Zang Y . DPABI: Data Processing & Analysis for (Resting-State) Brain Imaging. Neuroinformatics. 2016; 14(3):339-51. DOI: 10.1007/s12021-016-9299-4. View

2.
Holze F, Vizeli P, Muller F, Ley L, Duerig R, Varghese N . Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects. Neuropsychopharmacology. 2019; 45(3):462-471. PMC: 6969135. DOI: 10.1038/s41386-019-0569-3. View

3.
Abou-Elseoud A, Starck T, Remes J, Nikkinen J, Tervonen O, Kiviniemi V . The effect of model order selection in group PICA. Hum Brain Mapp. 2010; 31(8):1207-16. PMC: 6871136. DOI: 10.1002/hbm.20929. View

4.
Mithoefer M, Grob C, Brewerton T . Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. Lancet Psychiatry. 2016; 3(5):481-8. DOI: 10.1016/S2215-0366(15)00576-3. View

5.
Whitfield-Gabrieli S, Nieto-Castanon A . Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect. 2012; 2(3):125-41. DOI: 10.1089/brain.2012.0073. View